JJ Quality LLC v. MedInfo, Inc. — Voluntary Dismissal After 113 Days
JJ Quality LLC filed a patent infringement action against MedInfo, Inc. in the Southern District of California, asserting US12036812B2 in connection with the First Lifesaver product. The case closed after 113 days when plaintiff voluntarily dismissed without prejudice under Rule 41(a)(1)(A)(i), preserving the right to refile.
Early voluntary exit leaves First Lifesaver patent dispute unresolved
On 26 August 2024, JJ Quality LLC filed a patent infringement complaint against MedInfo, Inc. in the United States District Court for the Southern District of California (Case No. 3:24-cv-01512). The plaintiff asserted US12036812B2, a patent linked to application number US17/967610, in connection with the First Lifesaver product (ASIN B0CKLXPBL7). Lynch LLP represented the plaintiff, while MedInfo, Inc. retained Payne & Fears LLP as defence counsel.
The case closed on 17 December 2024 — just 113 days after filing — when JJ Quality LLC filed a notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). The dismissal was without prejudice, meaning the merits of the infringement allegations were never adjudicated. Because the dismissal was filed before MedInfo, Inc. served an answer or a motion for summary judgment, no court approval was required and no conditions were imposed.
A resolution within 113 days, before any substantive briefing, is consistent with several scenarios: early licensing discussions, a design-around by the defendant, strategic reassessment by the plaintiff, or an undisclosed settlement. The public record does not reveal which factor was determinative. Because the dismissal is without prejudice, JJ Quality LLC retains the right to refile substantially identical claims, and the underlying patent — US12036812B2 — remains a live enforcement asset.
Filing to Dismissed without Prejudice in 113 days
113 days — resolved before any substantive court ruling, suggesting early-stage resolution
Voluntarily dismissed: what Rule 41 without prejudice means for both parties
Rule 41(a)(1)(A)(i): plaintiff’s unilateral exit right
Fed. R. Civ. P. 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order at any time before the defendant serves an answer or a motion for summary judgment. JJ Quality LLC exercised this right, meaning the court never ruled on jurisdiction, claim construction, or the merits of infringement. The dismissal is self-executing and imposes no conditions on either party.
No merits adjudicationWithout prejudice confirmed — but what does that actually mean?
A dismissal without prejudice means the lawsuit is terminated but the plaintiff is not barred from refiling the same claims. This is distinct from a dismissal with prejudice, which would extinguish the cause of action permanently. The verdict text in this case explicitly states ‘without prejudice,’ so there is no ambiguity: JJ Quality LLC retains full rights to assert US12036812B2 against MedInfo, Inc. again in future proceedings.
Refile right preservedMedInfo escapes judgment — but patent risk persists
MedInfo, Inc. faces no adverse judgment, injunction, or damages award as a result of this dismissal. However, because the dismissal is without prejudice, the threat of re-assertion under US12036812B2 remains real. MedInfo should consider whether to pursue an IPR or declaratory judgment action to obtain finality, particularly if it continues selling or developing products in the First Lifesaver technology space.
No judgment; risk unresolvedUS12036812B2 remains an active enforcement risk for the sector
The voluntary dismissal without prejudice leaves US12036812B2 fully enforceable. Competitors operating in the First Lifesaver product category should treat this patent as a continuing threat. The short litigation window — 113 days — suggests JJ Quality LLC may be testing enforcement strategies or negotiating licensing terms. Companies in adjacent medical or safety device segments should conduct FTO analysis against this patent before product launch or expansion.
Patent enforcement risk liveFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | JJ Quality LLC | Company | Patent assertion entity or product company — holder of US12036812B2 (First Lifesaver)Search in Eureka ↗ |
| Defendant | MedInfo, Inc. | Company | MedInfo, Inc. — California-based company alleged to infringe the First Lifesaver patentSearch in Eureka ↗ |
| Plaintiff counsel | Connor T. Lynch | Attorney | Counsel for JJ Quality LLCSearch in Eureka ↗ |
| Plaintiff counsel | Sean M Lynch | Attorney | Counsel for JJ Quality LLCSearch in Eureka ↗ |
| Plaintiff law firm | Lynch LLP | Law Firm | Representing JJ Quality LLCSearch in Eureka ↗ |
| Defendant counsel | Sean A. O’Brien | Attorney | Counsel for MedInfo, Inc.Search in Eureka ↗ |
| Defendant law firm | Payne & Fears LLP | Law Firm | Representing MedInfo, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | California Southern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i) and explicitly states the action is dismissed ‘without prejudice.’ This is a unilateral plaintiff notice, not a court order, meaning no judicial analysis of the merits occurred. The phrasing forecloses any argument that the dismissal carries preclusive effect. MedInfo, Inc. cannot rely on this termination as a defence in any future proceeding asserting the same patent claims. The without-prejudice designation is the operative legal fact for both parties going forward.
US12036812B2 — First Lifesaver product technology
US12036812B2, filed under application number US17/967610, is the sole patent asserted in this action. The patent is associated with the First Lifesaver product (ASIN B0CKLXPBL7), suggesting a consumer-facing safety or medical device application. The application number and B2 grant designation indicate the patent has completed examination and issued with full grant status, giving the holder the right to exclude others from making, using, or selling the claimed invention within the United States.
For competitors operating in the safety device or medical consumer product space, US12036812B2 represents an active enforcement asset. The fact that JJ Quality LLC was willing to litigate in federal court — even briefly — signals genuine enforcement intent. The patent’s association with a specific ASIN suggests the claims may be product-specific, potentially limiting scope, but this has not been tested in claim construction proceedings. Companies developing or distributing comparable products should assess freedom-to-operate against this patent before commercialisation.
Should you run an FTO analysis against US12036812B2?
Any company developing, manufacturing, or distributing products in the First Lifesaver product category — or adjacent safety and medical device segments — should treat US12036812B2 as a live risk. The patent has been actively asserted in federal court, no claim construction ruling exists to narrow its scope, and the without-prejudice dismissal means enforcement can resume at any time. Product teams launching new SKUs in this space should commission an FTO before going to market.
PatSnap Eureka’s FTO Search Agent can map the claims of US12036812B2 against your product specifications, identify prior art that could support invalidity arguments, and flag related continuation or family patents that may create additional exposure. Eureka also monitors prosecution history for claim amendments — critical intelligence if JJ Quality LLC broadens claims ahead of a refile. Run your FTO analysis before the next enforcement action lands.
Run a freedom-to-operate analysis on US12036812B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent infringement cases in safety & medical device technology
Comparable infringement actions asserting consumer safety or medical device patents in the Southern District of California and related federal venues.
What this case signals for the First Lifesaver patent IP landscape
A 113-day voluntary exit in S.D. Cal. rarely closes the chapter — it often marks the start of a broader enforcement or licensing play.
Without-prejudice dismissals are enforcement resets, not endings
JJ Quality LLC’s Rule 41(a)(1)(A)(i) dismissal preserves every enforcement option. Patent holders using this mechanism frequently refile — sometimes in a different venue or after claim amendments. Competitors in the First Lifesaver product space should monitor US12036812B2 for continuation filings and reissue activity that could broaden claim scope ahead of a second enforcement wave.
Early dismissal suggests leverage — not defeat — for the patent holder
Cases resolved in under 120 days before any answer is filed typically reflect one of three dynamics: undisclosed settlement, licensing agreement reached, or strategic withdrawal pending stronger evidence. The absence of any public settlement record means the dispute may resurface. MedInfo, Inc. and similarly situated defendants should document non-infringement positions and prior art now, while memories and records are fresh.
JJ v MedInfo — key questions answered
JJ Quality LLC dismissed the action under Rule 41(a)(1)(A)(i), which allows a plaintiff to exit before the defendant answers without court approval. The without-prejudice designation means no merits ruling was made and JJ Quality retains the right to refile the same claims asserting US12036812B2 against MedInfo, Inc. in the future.
Yes. Because the dismissal is expressly without prejudice, JJ Quality LLC is not barred from refiling substantially the same infringement claims based on US12036812B2. The plaintiff could refile in the Southern District of California or another appropriate venue, subject to applicable statutes of limitations and any strategic considerations regarding venue or claim scope.
US12036812B2 is a granted US patent filed under application number US17/967610. It is associated with the First Lifesaver product (ASIN B0CKLXPBL7), indicating coverage of a consumer safety or medical device technology. The B2 designation confirms the patent issued after full examination. The precise claim scope has not been construed by any court in this litigation.
No. A dismissal without prejudice does not create res judicata or collateral estoppel protection for MedInfo, Inc. The company could face a refiled action asserting US12036812B2 at any time. To obtain finality, MedInfo could consider filing an IPR petition against the patent or seeking a declaratory judgment of non-infringement or invalidity, subject to standing requirements.
The public record does not disclose the reason. Common explanations for a Rule 41(a)(1)(A)(i) dismissal within 113 days include: reaching a confidential licensing or settlement agreement, deciding to refile in a more favourable venue, reassessing claim strength following initial legal analysis, or responding to a design-around by the defendant. None of these scenarios can be confirmed from the available case data.
PatSnap Eureka searches patents and litigation data to answer instantly.